VLGEA Q1 2025 Earnings Profitability Holds Steady Amidst Challenging Retail Environment TAC Q1 2026 Earnings EPS Misses Estimates but Stock Rises on Operational Momentum BSAC Q1 2026 Earnings Earnings Beat Estimates as Net Income Rises Stock Slightly Down Syndax Pharmaceuticals Q1 2026 Earnings Narrowed Loss Beats Estimates as Pipeline Progress Continues FSP Q4 2025 Earnings Significant EPS Beat Masks Revenue Disclosures